Targeted Delivery of Carbon Monoxide

Berreau, Lisa M.

doi:10.1002/9781119783435.ch15

Cited by 3 publications

(1 citation statement)

References 155 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is easy to think of selective delivery to the GI (Steiger et al, 2017;Bakalarz et al, 2021). However, selective CO delivery toward intended organs, tissues, cell types, or organelles is much harder (Berreau, 2022). Along this line, there have been reports of mitochondria-targeted delivery of CO (Zheng et al, 2018;Lazarus et al, 2022) leading to improved potency in animal models (Zheng et al, 2018).…”

Section: Discussionmentioning

confidence: 99%

Carbon Monoxide Signaling: Examining Its Engagement with Various Molecular Targets in the Context of Binding Affinity, Concentration, and Biologic Response

et al. 2022

View full text Add to dashboard Cite

Carbon monoxide (CO) has been firmly established as an endogenous signaling molecule with a variety of pathophysiological and pharmacological functions, including immunomodulation, organ protection, and circadian clock regulation, among many others. In terms of its molecular mechanism(s) of action, CO is known to bind to a large number of hemoproteins with at least 25 identified targets, including hemoglobin, myoglobin, neuroglobin, cytochrome c oxidase, cytochrome P450, soluble guanylyl cyclase, myeloperoxidase, and some ion channels with dissociation constant values spanning the range of sub-nM to high lM. Although CO's binding affinity with a large number of targets has been extensively studied and firmly established, there is a pressing need to incorporate such binding information into the analysis of CO's biologic response in the context of affinity and dosage. Especially important is to understand the reservoir role of hemoglobin in CO storage, transport, distribution, and transfer. We critically review the literature and inject a sense of quantitative assessment into our analyses of the various relationships among binding affinity, CO concentration, target occupancy level, and anticipated pharmacological actions. We hope that this review presents a picture of the overall landscape of CO's engagement with various targets, stimulates additional research, and helps to move the CO field in the direction of examining individual targets in the context of all of the targets and the concentration of available CO. We believe that such work will help the further understanding of the relationship of CO concentration and its pathophysiological functions and the eventual development of CO-based therapeutics.-Significance Statement--The further development of carbon monoxide (CO) as a therapeutic agent will significantly rely on the understanding of CO's engagement with therapeutically relevant targets of varying affinity. This review critically examines the literature by quantitatively analyzing the intricate relationships among targets, target affinity for CO, CO level, and the affinity state of carboxyhemoglobin and provide a holistic approach to examining the molecular mechanism(s) of action for CO.

show abstract